SGLT2 inhibitors and risk of cancer in type 2 diabetes: a systematic review and meta-analysis of randomised controlled trials.
about
SGLT2 inhibitors: are they safe?Dapagliflozin and saxagliptin tablets for adults with type 2 diabetes.Cancer risk in the EMPA-REG OUTCOME trial. Reply to Shaikh AMY [letter] and Kohler S, Lee J, George JT et al [letter].Bladder cancer in the EMPA-REG OUTCOME trial.SGLT2 inhibitors and cancer: why further evidence is required.
P2860
SGLT2 inhibitors and risk of cancer in type 2 diabetes: a systematic review and meta-analysis of randomised controlled trials.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
SGLT2 inhibitors and risk of c ...... randomised controlled trials.
@en
type
label
SGLT2 inhibitors and risk of c ...... randomised controlled trials.
@en
prefLabel
SGLT2 inhibitors and risk of c ...... randomised controlled trials.
@en
P2093
P2860
P1433
P1476
SGLT2 inhibitors and risk of c ...... randomised controlled trials.
@en
P2093
P2860
P2888
P304
P356
10.1007/S00125-017-4370-8
P577
2017-07-19T00:00:00Z
P6179
1090804243